| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCAGUUCCUGAGAGAAGAACCCUGAGGAACAGACGUUCCCUCGCGGCCC… | 966 nt | 0.5280 | |
| GCAGUUCCUGAGAGAAGAACCCUGAGGAACAGACGUUCCCUCGCGGCCC… | 1754 nt | 0.5587 | |
| GCAGUUCCUGAGAGAAGAACCCUGAGGAACAGACGUUCCCUCGCGGCCC… | 1475 nt | 0.5437 |
Predicted to enable sialic acid binding activity. Predicted to be involved in cell adhesion. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
A study in humans using Summary data-based Mendelian randomization analysis of GWAS data from 456,348 European samples identified the SIGLEC7 as having expression levels pleiotropically associated with sepsis, noting it is an important negative regulator of acute inflammatory responses and a potential therapeutic target for the condition [Yang et al. DOI:10.1111/jcmm.18559]. A meta-analysis of human mild traumatic brain injury (mTBI) patients identified the SIGLEC7 as a key hub protein within a neurodegeneration-associated interaction network, where its deficiency is associated with poorer TBI outcome [Matyasova et al. DOI:10.4149/gpb_2021038]. A separate single-cell transcriptomic study in a rat model of radiation-induced lung injury identified the orthologous rat gene *Tnfrsf1b* as being associated with inflammatory processes [Shi et al. DOI:10.17305/bb.2024.10357].